Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of a Novel Blood Test in Early Detection of the Five Common Cancers Based on the Investigation of the Circulating Tumour DNA

NCT05227261 is registered in ClinicalTrials.gov with Gene Solutions as lead sponsor.

NCT NCT05227261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of a Novel Blood Test in Early Detection of the Five Common Cancers Based on the Investigation of the Circulating Tumour DNA
Lead sponsor
Gene Solutions
Phase
Observational
Overall status
Completed
Start date
April 10, 2022
Completion date
April 10, 2024
Enrollment
9,057 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer liver, cancer, breast, cancer, colorectal, cancer, gastric, cancer, lung, circulating tumour dna, liquid biopsy